Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Buy
59
CBAN Quote, Financials, Valuation and Earnings
Last price:
$17.72
Seasonality move
:
-0.92%
Day range:
$17.80 - $17.98
52-week range:
$13.99 - $18.80
Dividend yield:
2.58%
P/E ratio:
11.19x
P/S ratio:
1.69x
P/B ratio:
1.03x
Volume:
76.9K
Avg. volume:
84.4K
1-year change:
10.41%
Market cap:
$310.7M
Revenue:
$176.8M
EPS (TTM):
$1.59
Analysts' Opinion
-
Consensus RatingColony Bankcorp, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $19.75, Colony Bankcorp, Inc. has an estimated upside of 10.83% from its current price of $17.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $18.50 representing 100% downside risk from its current price of $17.82.
Fair Value
-
According to the consensus of 2 analysts, Colony Bankcorp, Inc. has 10.83% upside to fair value with a price target of $19.75 per share.
CBAN vs. S&P 500
-
Over the past 5 trading days, Colony Bankcorp, Inc. has overperformed the S&P 500 by 0.05% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Colony Bankcorp, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Colony Bankcorp, Inc. has grown year-over-year revenues for 35 quarters straight. In the most recent quarter Colony Bankcorp, Inc. reported revenues of $47M.
Earnings Growth
-
Colony Bankcorp, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Colony Bankcorp, Inc. reported earnings per share of $0.33.
Enterprise value:
558.8M
EV / Invested capital:
--
Price / LTM sales:
1.69x
EV / EBIT:
6.00x
EV / Revenue:
3.02x
PEG ratio (5yr expected):
0.42x
EV / Free cash flow:
11.08x
Price / Operating cash flow:
6.18x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.89%
Net Income Margin (TTM):
15.07%
Return On Equity:
9.68%
Return On Invested Capital:
5.2%
Operating Margin:
17.05%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $152.1M | $172.8M | $184.8M | $44.7M | $47M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | $26.5M | $27.8M | $35.2M | $7M | $8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.23 | $1.25 | $1.59 | $0.32 | $0.33 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $177.8M | $85.3M | $154.9M | $157.9M | $214M | |
| Total Assets | $2.5B | $2.8B | $3.1B | $3.1B | $3.2B | |
| Current Liabilities | $1.3B | $648.3M | $1.3B | $1.3B | $1.3B | |
| Total Liabilities | $2.3B | $2.6B | $2.9B | $2.8B | $2.9B | |
| Total Equity | $217.1M | $226.1M | $238.7M | $276.1M | $302.3M | |
| Total Debt | $89.4M | $158.4M | $248.4M | $248M | $248.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $27.9M | $24.7M | $51.8M | $5.9M | $14.4M | |
| Cash From Investing | -$234.4M | $54.6M | -$45.6M | $14.9M | $47.5M | |
| Cash From Financing | $262.8M | -$75.8M | $48.9M | $42M | $25.9M | |
| Free Cash Flow | $23.5M | $23.5M | $50.4M | $5.6M | $14.1M | |
CBAN
Sector
Market Cap
$310.7M
$554M
Price % of 52-Week High
94.79%
90.96%
Dividend Yield
2.58%
1.58%
Shareholder Yield
4.75%
3.08%
1-Year Price Total Return
10.41%
6.77%
Beta (5-Year)
0.658
0.463
Dividend yield:
2.58%
Annualized payout:
$0.45
Payout ratio:
34.51%
Growth streak:
7 years
Technicals
8-day SMA
Sell
Level
$18.03
200-day SMA
Buy
Level
$16.50
Bollinger Bands (100)
Buy
Level
16.31 - 17.73
Chaikin Money Flow
Sell
Level
-419.9K
20-day SMA
Sell
Level
$18.00
Relative Strength Index (RSI14)
Buy
Level
52.99
ADX Line
Buy
Level
26.88
Williams %R
Buy
Level
-98
50-day SMA
Buy
Level
$17.06
MACD (12, 26)
Buy
Level
0.26
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Sell
Level
-121.6K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.3678)
Sell
CA Score
(Annual)
Level (-2.2093)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (3.947)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Colony Bankcorp, Inc. is a bank holding company, which engages in the stockholder and investor relations functions through its subsidiary, Colony Bank. It operates through the following segments: Banking Division, Mortgage Division, and Small Business Specialty Lending Division. The Banking Division segment offers full service financial services including commercial loans, consumer loans and deposit accounts. The Mortgage Division segment consists of sales and servicing of one-to-four family residential mortgage loans. The Small Business Specialty Lending Division segment focuses on the selling and servicing of SBA and USDA government guaranteed loans. The company was founded on November 8, 1982 and is headquartered in Fitzgerald, GA.
Stock Forecast FAQ
In the current month, CBAN has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CBAN average analyst price target in the past 3 months is $19.75.
-
Where Will Colony Bankcorp, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Colony Bankcorp, Inc. share price will rise to $19.75 per share over the next 12 months.
-
What Do Analysts Say About Colony Bankcorp, Inc.?
Analysts are divided on their view about Colony Bankcorp, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Colony Bankcorp, Inc. is a Sell and believe this share price will drop from its current level to $18.50.
-
What Is Colony Bankcorp, Inc.'s Price Target?
The price target for Colony Bankcorp, Inc. over the next 1-year time period is forecast to be $19.75 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CBAN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Colony Bankcorp, Inc. is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of CBAN?
You can purchase shares of Colony Bankcorp, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Colony Bankcorp, Inc. shares.
-
What Is The Colony Bankcorp, Inc. Share Price Today?
Colony Bankcorp, Inc. was last trading at $17.72 per share. This represents the most recent stock quote for Colony Bankcorp, Inc.. Yesterday, Colony Bankcorp, Inc. closed at $17.82 per share.
-
How To Buy Colony Bankcorp, Inc. Stock Online?
In order to purchase Colony Bankcorp, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get CBAN Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CBAN
Sector
P/E ratio
11.19x
12.15x
PEG ratio
0.42x
0.31x
P/B ratio
1.03x
1.10x
Price / LTM sales
1.69x
1.82x
Growth Metrics
CBAN
Sector
Revenue growth
5.14%
5.54%
Earnings growth
4.13%
14.85%
Revenue (5-year growth)
18.63%
8.84%
Earnings forecast
$0.46
$0.64
Profitability
CBAN
Sector
Profitability FY 2024
--
--
Return on invested capital
5.2%
5.01%
Return on assets
0.89%
1.01%
Return on equity
9.68%
9.67%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Jan
21
Estimated Next Earnings Date
Jan
21
Balance Sheet
CBAN
Sector
Total cash
$278.6M
$430.8M
Short term investments
$38.8M
$211.1M
Total assets
$3.1B
$3.1B
Long term debt
$248.1M
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
